Qube Research & Technologies Ltd - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 203 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q1 2024$135,341
-92.6%
1,696
-92.9%
0.00%
-100.0%
Q4 2022$1,834,614
-66.2%
23,786
-80.5%
0.01%
-68.8%
Q3 2022$5,435,000121,8100.03%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 991,754$58,345,00037.79%
VR Adviser, LLC 810,000$47,652,00012.91%
ACUTA CAPITAL PARTNERS, LLC 308,500$18,149,0008.80%
Fairmount Funds Management LLC 189,598$11,154,0006.76%
RA Capital Management 1,904,094$112,018,0003.54%
Ghost Tree Capital, LLC 215,000$12,648,0003.36%
MORGAN JESS S & CO INC 42,402$2,495,0003.24%
RTW INVESTMENTS, LP 1,052,969$61,946,0002.67%
EAM Global Investors LLC 50,649$2,980,0001.74%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,172,014$68,950,0001.67%
View complete list of AXSOME THERAPEUTICS INC shareholders